BIRC5 and liver cancer: With the treatment of Raloxifene for 24 hours, the expression of Bcl-2, Bcl-xl, and survivin was reduced in Hep-G2 (Figure 3A), 7721 (Figure 3B), and Huh-7 (Figure 3C) liver cancer cell-lines.